Low-Dose Interleukin 2 in Children with Recently Diagnosed Type 1 Diabetes: A Phase 1/2 Randomised, Double-Blind, Placebo-Controlled Dose Finding Study

2019 ◽  
Author(s):  
Randa Salet ◽  
Michelle Rosenzwajg ◽  
Roberta Lorenzon ◽  
Alexandra Roux ◽  
Jean Claude Carel ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Low Dose ◽  
Phase 1 ◽  
Interleukin 2 ◽  
Dose Finding ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Finding Study ◽  
Dose Finding Study

scholarly journals Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study

Diabetologia ◽  
2020 ◽  
Vol 63 (9) ◽  
pp. 1808-1821 ◽  
Author(s):  
Michelle Rosenzwajg ◽  
Randa Salet ◽  
Roberta Lorenzon ◽  
Nicolas Tchitchek ◽  
Alexandra Roux ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Phase I ◽  
Low Dose ◽  
Dose Finding ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Finding Study ◽  
Dose Finding Study

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial

2013 ◽  
Vol 1 (4) ◽  
pp. 295-305 ◽  
Author(s):  
Agnès Hartemann ◽  
Gilbert Bensimon ◽  
Christine A Payan ◽  
Sophie Jacqueminet ◽  
Olivier Bourron ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Low Dose ◽  
Controlled Trial ◽  
Phase 1 ◽  
Interleukin 2 ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document